1.Townsend, N, Wickramasinghe, K, Bhatnagar, P et al. (2012) Coronary Heart Disease Statistics 2012 Edition. London: British Heart Foundation.
2.Bhatnagar, P, Wickramasinghe, K, Williams, J et al. (2015) The epidemiology of cardiovascular disease in the UK 2014. Heart (British Cardiac Society) 101, 1182–1189.
3.Frayn, KN, Stanner, S (editors) (2005) Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors: The Report of a British Nutrition Foundation Task Force. Oxford: Blackwell Pub.
4.Gimbrone, MA Jr & Garcia-Cardena, G (2016) Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118, 620–636.
5.Sena, CM, Pereira, AM & Seica, R (2013) Endothelial dysfunction – a major mediator of diabetic vascular disease. Biochim Biophys Acta 1832, 2216–2231.
6.Michiels, C (2003) Endothelial cell functions. J Cell Physiol 196, 430–443.
7.Rajendran, P, Rengarajan, T, Thangavel, J et al. (2013) The vascular endothelium and human diseases. Int J Biol Sci 9, 1057–1069.
8.Sumpio, BE, Riley, JT & Dardik, A (2002) Cells in focus: endothelial cell. Int J Biochem Cell Biol 34, 1508–1512.
9.Mensah, GA (2007) Healthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease prevention. Vascul Pharmacol 46, 310–314.
10.Vanhoutte, PM, Shimokawa, H, Tang, EH et al. (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196, 193–222.
11.Siervo, M, Capuano, L & Colantuoni, A (2010) [Physiology and in vivo measurements of nitric oxide in man]. Clin Ter 161, 173–183.
12.Yetik-Anacak, G & Catravas, JD (2006) Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol 45, 268–276.
13.Channon, KM (2006) The endothelium and the pathogenesis of atherosclerosis. Medicine 34, 173–177.
14.Lei, J, Vodovotz, Y, Tzeng, E et al. (2013) Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide 35C, 175–185.
15.Forstermann, U & Sessa, WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33, 829–837, 837a–837d.
16.Khazaei, M, Moien-Afshari, F & Laher, I (2008) Vascular endothelial function in health and diseases. Pathophysiology 15, 49–67.
17.Forstermann, U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459, 923–939.
18.Versari, D, Daghini, E, Virdis, A et al. (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. Diab Care 32, Suppl. 2, S314–S321.
19.Giles, TD (2006) Aspects of nitric oxide in health and disease: a focus on hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 8, 2–16.
20.North, BJ & Sinclair, DA (2012) The intersection between aging and cardiovascular disease. Circ Res 110, 1097–1108.
21.Schmidt, TS & Alp, NJ (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 113, 47–63.
22.Toda, N & Toda, H (2010) Nitric oxide-mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol 649, 1–13.
23.Sibal, L, Agarwal, SC, Home, PD et al. (2010) The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 6, 82–90.
24.Dayal, S & Lentz, SR (2005) ADMA and hyperhomocysteinemia. Vasc Med 10, Suppl. 1, S27–S33.
25.Tang, EH & Vanhoutte, PM (2010) Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch 459, 995–1004.
26.Linder, L, Kiowski, W, Buhler, FR et al. (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81, 1762–1767.
27.Panza, JA, Quyyumi, AA, Brush, JE Jr et al. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323, 22–27.
28.Panza, JA, Casino, PR, Kilcoyne, CM et al. (1993) Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87, 1468–1474.
29.Dobrovic, A & Kristensen, LS (2009) DNA methylation, epimutations and cancer predisposition. Int J Biochem Cell Biol 41, 34–39.
30.Vijg, J & Suh, Y (2013) Genome instability and aging. Annu Rev Physiol 75, 645–668.
31.Ashor, AW, Siervo, M & Mathers, JC (2016) Chapter 43 – vitamin C, antioxidant status, and cardiovascular aging A2 – Malavolta, Marco. In Molecular Basis of Nutrition and Aging, pp. 609–619 [Mocchegiani, E, editor]. San Diego: Academic Press.
32.Lopez-Otin, C, Blasco, MA, Partridge, L et al. (2013) The hallmarks of aging. Cell 153, 1194–1217.
33.Mathers, JC (2015) Impact of nutrition on the ageing process. Br J Nutr 113, Suppl, S18–S22.
34.Ungvari, Z, Kaley, G, de Cabo, R et al. (2010) Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 65, 1028–1041.
35.Murray, CJ, Richards, MA, Newton, JN et al. (2013) UK health performance: findings of the global burden of disease study 2010. Lancet 381, 997–1020.
36.Jani, B & Rajkumar, C (2006) Ageing and vascular ageing. Postgrad Med J 82, 357–362.
37.Mitchell, GF, Parise, H, Benjamin, EJ et al. (2004) Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham heart study. Hypertension 43, 1239–1245.
38.Taddei, S, Virdis, A, Ghiadoni, L et al. (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274–279.
39.El Assar, M, Angulo, J, Vallejo, S et al. (2012) Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 3, 132.
40.Puca, AA, Carrizzo, A, Villa, F et al. (2013) Vascular ageing: the role of oxidative stress. Int J Biochem Cell Biol 45, 556–559.
41.Fusco, D, Colloca, G, Lo Monaco, MR et al. (2007) Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2, 377–387.
42.Zorov, DB, Juhaszova, M & Sollott, SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94, 909–950.
43.Bedard, K & Krause, KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245–313.
44.Birben, E, Sahiner, UM, Sackesen, C et al. (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5, 9–19.
45.Drummond, GR & Sobey, CG (2014) Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends Endocrinol Metab 25, 452–463.
46.Turgeon, J, Haddad, P, Dussault, S et al. (2012) Protection against vascular aging in Nox2-deficient mice: impact on endothelial progenitor cells and reparative neovascularization. Atherosclerosis 223, 122–129.
47.Kornfeld, OS, Hwang, S, Disatnik, MH et al. (2015) Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases. Circ Res 116, 1783–1799.
48.Panth, N, Paudel, KR & Parajuli, K (2016) Reactive oxygen species: a key hallmark of cardiovascular disease. Adv Med 2016, 12.
49.Kuroda, J, Ago, T, Matsushima, S et al. (2010) NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 107, 15565–15570.
50.Dromparis, P & Michelakis, ED (2013) Mitochondria in vascular health and disease. Annu Rev Physiol 75, 95–126.
51.Shiva, S & Gladwin, MT (2009) Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104, 113–119.
52.Chung, HY, Cesari, M, Anton, S et al. (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8, 18–30.
53.Akbaraly, TN, Hamer, M, Ferrie, JE et al. (2013) Chronic inflammation as a determinant of future aging phenotypes. CMAJ 185, E763–E770.
54.Herrera, MD, Mingorance, C, Rodriguez-Rodriguez, R et al. (2010) Endothelial dysfunction and aging: an update. Ageing Res Rev 9, 142–152.
55.Vita, JA, Keaney, JF Jr, Larson, MG et al. (2004) Brachial artery vasodilator function and systemic inflammation in the Framingham offspring study. Circulation 110, 3604–3609.
56.Pierce, GL, Lesniewski, LA, Lawson, BR et al. (2009) Nuclear factor-KB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 119, 1284–1292.
57.Erusalimsky, JD (2009) Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol (1985) 106, 326–332.
58.Fyhrquist, F & Saijonmaa, O (2012) Telomere length and cardiovascular aging. Ann Med 44, Suppl. 1, S138–S142.
59.Aviv, H, Khan, MY, Skurnick, J et al. (2001) Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 159, 281–287.
60.Ogami, M, Ikura, Y, Ohsawa, M et al. (2004) Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 24, 546–550.
61.Nawrot, TS, Staessen, JA, Holvoet, P et al. (2010) Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking. Front Biosci (Elite Ed) 2, 1164–1168.
62.Minamino, T, Miyauchi, H, Yoshida, T et al. (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 1541–1544.
63.Minamino, T & Komuro, I (2007) Vascular cell senescence: contribution to atherosclerosis. Circ Res 100, 15–26.
64.Farsetti, A, Grasselli, A, Bacchetti, S et al. (2009) The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling. J Appl Physiol (1985) 106, 333–337.
65.Cau, SB, Carneiro, FS & Tostes, RC (2012) Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol 3, 218.
66.Seals, DR, Kaplon, RE, Gioscia-Ryan, RA et al. (2014) You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging. Physiology (Bethesda, Md) 29, 250–264.
67.Sindler, AL, Devan, AE, Fleenor, BS et al. (2014) Inorganic nitrite supplementation for healthy arterial aging. J Appl Physiol (1985) 116, 463–477.
68.Zhan, J, Liu, YJ, Cai, LB et al. (2017) Fruit and vegetable consumption and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 57, 1650–1663.
69.Hord, NG, Tang, Y & Bryan, NS (2009) Food sources of nitrates and nitrites: the physiologic context for potential health benefits1–3. Am J Clin Nutr 90, 1–10.
70.Lidder, S & Webb, AJ (2013) Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol 75, 677–696.
71.Bryan, NS & Ivy, JL (2015) Inorganic nitrite and nitrate: evidence to support consideration as dietary nutrients. Nutr Res (New York, NY) 35, 643–654.
72.Kelm, M (1999) Nitric oxide metabolism and breakdown. Biochim Biophys Acta (BBA) – Bioenerg 1411, 273–289.
73.Zweier, JL, Wang, P, Samouilov, A et al. (1995) Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1, 804–809.
74.Lundberg, JO, Weitzberg, E & Gladwin, MT (2008) The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7, 156.
75.Zweier, JL, Samouilov, A & Kuppusamy, P (1999) Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1411, 250–262.
76.Bailey, JC, Feelisch, M, Horowitz, JD et al. (2014) Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation. Pharmacol Ther 144, 303–320.
77.Butler, AR & Feelisch, M (2008) Therapeutic uses of inorganic nitrite and nitrate: from the past to the future. Circulation 117, 2151–2159.
78.Lundberg, JO, Feelisch, M, Bjorne, H et al. (2006) Cardioprotective effects of vegetables: is nitrate the answer? Nitric Oxide 15, 359–362.
79.Kevil, CG, Kolluru, GK, Pattillo, CB et al. (2011) Inorganic nitrite therapy: historical perspective and future directions. Free Radic Biol Med 51, 576–593.
80.Zweier, JL, Li, H, Samouilov, A et al. (2010) Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall. Nitric Oxide 22, 83–90.
81.Kim-Shapiro, DB & Gladwin, MT (2014) Mechanisms of nitrite bioactivation. Nitric Oxide 38, 58–68.
82.Machha, A & Schechter, AN (2012) Inorganic nitrate: a major player in the cardiovascular health benefits of vegetables? Nutr Rev 70, 367–372.
83.Kapil, V, Weitzberg, E, Lundberg, JO et al. (2014) Clinical evidence demonstrating the utility of inorganic nitrate in cardiovascular health. Nitric Oxide 38, 45–57.
84.Larsen, FJ, Ekblom, B, Sahlin, K et al. (2006) Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 355, 2792–2793.
85.Larsen, FJ, Weitzberg, E, Lundberg, JO et al. (2007) Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol (Oxf) 191, 59–66.
86.Rammos, C, Hendgen-Cotta, UB, Sobierajski, J et al. (2014) Dietary nitrate reverses vascular dysfunction in older adults with moderately increased cardiovascular risk. J Am Coll Cardiol 63, 1584–1585.
87.Jajja, A, Sutyarjoko, A, Lara, J et al. (2014) Beetroot supplementation lowers daily systolic blood pressure in older, overweight subjects. Nutr Res (New York, NY) 34, 868–875.
88.Kapil, V, Khambata, RS, Robertson, A et al. (2015) Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension 65, 320–327.
89.Bondonno, CP, Liu, AH, Croft, KD et al. (2015) Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial. Am J Clin Nutr 102, 368–375.
90.Siervo, M, Lara, J, Jajja, A et al. (2015) Ageing modifies the effects of beetroot juice supplementation on 24-h blood pressure variability: an individual participant meta-analysis. Nitric Oxide 47, 97–105.
91.Siervo, M, Lara, J, Ogbonmwan, I et al. (2013) Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr 143, 818–826.
92.Lara, J, Ashor, AW, Oggioni, C et al. (2016) Effects of inorganic nitrate and beetroot supplementation on endothelial function: a systematic review and meta-analysis. Eur J Nutr 55, 451–459.
93.Stokes, KY, Dugas, TR, Tang, Y et al. (2009) Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol 296, H1281–H1288.
94.Velmurugan, S, Gan, JM, Rathod, KS et al. (2016) Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 103, 25–38.
95.Zand, J, Lanza, F, Garg, HK et al. (2011) All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans. Nutr Res (New York, NY) 31, 262–269.
96.Carlstrom, M, Larsen, FJ, Nystrom, T et al. (2010) Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA 107, 17716–17720.
97.Khalifi, S, Rahimipour, A, Jeddi, S et al. (2015) Dietary nitrate improves glucose tolerance and lipid profile in an animal model of hyperglycemia. Nitric Oxide 44, 24–30.
98.Cermak, NM, Hansen, D, Kouw, IW et al. (2015) A single dose of sodium nitrate does not improve oral glucose tolerance in patients with type 2 diabetes mellitus. Nutr Res (New York, NY) 35, 674–680.
99.Gilchrist, M, Winyard, PG, Aizawa, K et al. (2013) Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic Biol Med 60, 89–97.
100.Shepherd, AI, Gilchrist, M, Winyard, PG et al. (2015) Effects of dietary nitrate supplementation on the oxygen cost of exercise and walking performance in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled crossover trial. Free Radic Biol Med 86, 200–208.
101.Larsen, FJ, Schiffer, TA, Ekblom, B et al. (2014) Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans. Am J Clin Nutr 99, 843–850.
102.Ashor, AW, Chowdhury, S, Oggioni, C et al. (2016) Inorganic nitrate supplementation in young and old obese adults does not affect acute glucose and insulin responses but lowers oxidative stress. J Nutr 146, 2224–2232.
103.Sindler, AL, Fleenor, BS, Calvert, JW et al. (2011) Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell 10, 429–437.
104.Bahra, M, Kapil, V, Pearl, V et al. (2012) Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide 26, 197–202.
105.Liu, AH, Bondonno, CP, Croft, KD et al. (2013) Effects of a nitrate-rich meal on arterial stiffness and blood pressure in healthy volunteers. Nitric Oxide 35, 123–130.
106.Park, JW, Piknova, B, Huang, PL et al. (2013) Effect of blood nitrite and nitrate levels on murine platelet function. PLoS ONE 8, e55699.
107.Richardson, G, Hicks, SL, O'Byrne, S et al. (2002) The ingestion of inorganic nitrate increases gastric S-nitrosothiol levels and inhibits platelet function in humans. Nitric Oxide 7, 24–29.
108.Burnley-Hall, N, Abdul, F, Androshchuk, V et al. (2018) Dietary nitrate supplementation reduces circulating platelet-derived extracellular vesicles in coronary artery disease patients on clopidogrel therapy: a randomised, double-blind, placebo-controlled study. Thromb Haemost 118, 112–122.
109.Lundberg, JO, Carlstrom, M, Larsen, FJ et al. (2011) Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res 89, 525–532.
110.Ingram, TE, Fraser, AG, Bleasdale, RA et al. (2013) Low-dose sodium nitrite attenuates myocardial ischemia and vascular ischemia-reperfusion injury in human models. J Am Coll Cardiol 61, 2534–2541.
111.Schwarz, K, Singh, S, Parasuraman, SK et al. (2017) Inorganic nitrate in angina study: a randomized double-blind placebo-controlled trial. J Am Heart Assoc 6, e006478.
112.Kenjale, AA, Ham, KL, Stabler, T et al. (2011) Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol (1985) 110, 1582–1591.
113.Coggan, AR, Broadstreet, SR, Mahmood, K et al. (2017) Dietary nitrate increases VO2peak and performance but does not alter ventilation or efficiency in patients with heart failure with reduced ejection fraction. J Card Fail 24, 65–73.
114.Zamani, P, Tan, V, Soto-Calderon, H et al. (2017) Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction. Circ Res 120, 1151–1161.
115.Oggioni, C, Jakovljevic, DG, Klonizakis, M et al. (2018) Dietary nitrate does not modify blood pressure and cardiac output at rest and during exercise in older adults: a randomised cross-over study. Int J Food Sci Nutr 69, 74–83.
116.Webb, AJ, Patel, N, Loukogeorgakis, S et al. (2008) Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784–790.
117.Ashor, AW, Lara, J & Siervo, M (2017) Medium-term effects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults: a systematic review and meta-analysis. J Hypertens 35, 1353–1359.
118.Ghosh, SM, Kapil, V, Fuentes-Calvo, I et al. (2013) Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 61, 1091–1102.
119.Bondonno, CP, Liu, AH, Croft, KD et al. (2014) Short-term effects of nitrate-rich green leafy vegetables on blood pressure and arterial stiffness in individuals with high-normal blood pressure. Free Radic Biol Med 77, 353–362.
120.Kerley, CP, Dolan, E & Cormican, L (2017) Nitrate-rich beetroot juice selectively lowers ambulatory pressures and LDL cholesterol in uncontrolled but not controlled hypertension: a pilot study. Ir J Med Sci 186, 895–902.
121.Shaltout, HA, Eggebeen, J, Marsh, AP et al. (2017) Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction. Nitric Oxide: Biol Chem 69, 78–90.
122.Coggan, AR, Leibowitz, JL, Spearie, CA et al. (2015) Acute dietary nitrate intake improves muscle contractile function in patients with heart failure: a double-blind, placebo-controlled, randomized trial. Circ Heart Fail 8, 914–920.
123.Eggebeen, J, Kim-Shapiro, DB, Haykowsky, M et al. (2016). One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction. JACC Heart Fail 4, 428–437.
124.Chirinos, JA, Londono-Hoyos, F, Zamani, P et al. (2017) Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction. Eur J Heart Fail 19, 1507–1515.
125.Kemmner, S, Lorenz, G, Wobst, J et al. (2017) Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide 64, 7–15.